Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2021
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.
Journal: Lancet (London, England)
Published: January 11, 2019
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
Journal: Cancer chemotherapy and pharmacology
Published: August 30, 2018
The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS).
Journal: Journal of patient-reported outcomes
Published: May 10, 2018
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
Journal: Clinical therapeutics
Published: December 29, 2015
Long-term outcome in BRAF(V600E) melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 19, 2014
RAF inhibitors that evade paradoxical MAPK pathway activation.
Journal: Nature
Published: January 24, 2014
Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Journal: American journal of obstetrics and gynecology
Published: September 01, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026